Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Rapid neutralization test based on ELISPOT for detecting antibodies against rhinovirus 1B.

Journal of microbiological methods·2026
Same author

Ultrasound assessment of pleural invasion via visceral pleura interruption and arch distance-to-tumour diameter ratio in a rabbit model of subpleural lung cancer.

Translational lung cancer research·2026
Same author

NTM-DB: A Comprehensive Non-tuberculosis Mycobacteria Genomic Database.

Genomics, proteomics & bioinformatics·2026
Same author

The Gradient Energetic Modification Method to Optimize the Balance between Energy and Thermal Stability of Tetrazole-Fused Pyrazolopyrimidines.

Organic letters·2026
Same author

Status and influencing factors of active health behaviors in high-risk stroke populations: a cross-sectional study.

Frontiers in health services·2026
Same author

Murray-inspired hierarchical hollow Cu/TiO₂ catalysts as a silver lining for plasma-assisted CO₂ conversion: coupling cavity-shell matching with local discharge activation.

Journal of colloid and interface science·2026

相关实验视频

Updated: Jun 8, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

对于患有差异化甲状腺癌的老年患者的预后性诺莫格拉姆模型:基于人口的研究.

Dasong Wang1, Yan Yang, Hongwei Yang

  • 1Department of Breast and Thyroid Surgery, Suining Central Hospital, Suining, Sichuan Province, China.

Medicine
|November 4, 2024
PubMed
概括

一个新的预后模型准确地预测了差异化甲状腺癌 (DTC) 的老年患者的生存率. 年龄和瘤阶段等关键因素有助于估计整体和癌症特异性生存结果.

更多相关视频

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

222
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

1.7K

相关实验视频

Last Updated: Jun 8, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

222
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

1.7K

科学领域:

  • 在瘤学瘤学.
  • 老年医学 老年医学
  • 生物统计学 生物统计学

背景情况:

  • 分化甲状腺癌 (DTC) 影响老年人群,需要准确的预后工具.
  • 由于与年龄相关的并发症和不同的临床表现,预测老年DTC患者的结果具有挑战性.

研究的目的:

  • 为老年DTC患者开发和验证一个强大的预后模型.
  • 确定影响总生存率 (OS) 和癌症特异性生存率 (CSS) 的关键人口和临床因素.

主要方法:

  • 利用监测,流行病学和最终结果 (SEER) 数据库来获取患者数据 (2010-2019).
  • 用Cox比例危险回归用于因子识别和名录构造.
  • 使用内部 (7:3 分割) 和外部数据集验证模型,评估歧视 (一致性指数) 和校准.

主要成果:

  • 确定了OS的显著预后因素:年龄,婚姻状况,性别,多焦点,T,N和M阶段.
  • 确定了CSS的关键决定因素:年龄,瘤大小,多焦点性,T,N和M阶段.
  • 开发了具有高预测准确度和临床实用性的准确的诺米克图,通过决策曲线分析证实了这一点.

结论:

  • 开发的诺姆图可提供老年DTC患者的OS和CSS的可靠预测.
  • 这些模型提供了显著的临床净益,有助于治疗规划和患者管理.
  • 该研究强调了将人口统计和临床因素整合为老年DTC个性化预后的重要性.